vimarsana.com
Home
Live Updates
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries : vimarsana.com
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries : vimarsana.com
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
ZUG, Switzerland--(BUSINESS WIRE)--May 7, 2024--
Related Keywords
Singapore ,
Switzerland ,
Japan ,
Australia ,
United Kingdom ,
Taiwan ,
Jessica Cohen ,
Emil Ivanov ,
Christian Marcoux ,
Dermatol Venereol ,
Access Consortium ,
Chugai Pharmaceutical Co Ltd ,
European Medicines Agency ,
Drug Administration ,
European Academy Of Dermatology ,
Corporate Communications ,
Breakthrough Therapy ,
Priority Review ,
Injectable Aesthetics ,
Dermatological Skincare ,
Allergy Asthma ,
Allergy Clin ,
Venereology European ,
Eur Acad Dermatol ,
Participants With Prurigo Nodularis ,
Safety Study ,
Participants With Prurigo ,
Subjects With Moderate To Severe Atopic ,
Investor Relations ,
Business Wire ,